Is tamoxifen associated with an increased risk for thromboembolic complications in patients undergoing microvascular breast reconstruction?

Introduction: Tamoxifen is associated with a twofold increased risk of thromboembolic events. Third generation aromatase inhibitors (AIs), such as letrozole, anastrozole, and exemestane have therefore replaced tamoxifen in the adjuvant therapy of hormone receptor-positive breast cancer. A retrospect...

Descripción completa

Detalles Bibliográficos
Autores principales: Jokuszies, Andreas, Radtke, Christine, Betzler, Christopher, Branski, Ludwik, Krämer, Robert, Vogt, Peter M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: German Medical Science GMS Publishing House 2013
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575563/
https://www.ncbi.nlm.nih.gov/pubmed/23423877
http://dx.doi.org/10.3205/000173

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3575563/
https://www.ncbi.nlm.nih.gov/pubmed/23423877
http://dx.doi.org/10.3205/000173

Ejemplares similares